ホーム>>Signaling Pathways>> PROTAC>> Ligand for Target Protein for PROTAC>>BMS-1166-N-piperidine-COOH

BMS-1166-N-piperidine-COOH

カタログ番号GC63536

BMS-1166ベースの部分であるBMS-1166-N-ピペリジン-COOHは、リンカーを介してE3リガーゼリガンドに結合し、PROTAC PD-1/PD-L1 degrader-1を形成してPD-1/PD-L1を分解します。 BMS-1166 は、1.4 nM の IC50 を持つ強力な PD-1/PD-L1 相互作用阻害剤です。 BMS-1166 は、T 細胞活性化に対する PD-1/PD-L1 免疫チェックポイントの阻害効果に拮抗します。

Products are for research use only. Not for human use. We do not sell to patients.

BMS-1166-N-piperidine-COOH 化学構造

Cas No.: 2447066-00-2

サイズ 価格 在庫数 個数
5 mg
$540.00
在庫あり
10 mg
$945.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

BMS-1166-N-piperidine-COOH, the BMS-1166-based moiety, binds to E3 ligase ligand via a linker to form PROTAC PD-1/PD-L1 degrader-1 (HY-131183) to degrade PD-1/PD-L1[1]. BMS-1166 is a potent PD-1/PD-L1 interaction inhibitor with an IC50 of 1.4 nM. BMS-1166 antagonizes the inhibitory effect of PD-1/PD-L1 immune checkpoint on T cell activation[2].

[1]. Binbin Cheng, et al. Discovery of Novel Resorcinol Diphenyl Ether-Based PROTAC-like Molecules as Dual Inhibitors and Degraders of PD-L1. Eur J Med Chem. 2020 Aug 1;199:112377.
[2]. Guzik K, et al. Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1. J Med Chem. 2017 Jul 13;60(13):5857-5867.

レビュー

Review for BMS-1166-N-piperidine-COOH

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for BMS-1166-N-piperidine-COOH

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.